How airway structure affects lung diseases caused by pollution
The Role of Airway Morphology in Environmental LungDiseases
['FUNDING_OTHER'] · UNIVERSITY OF WASHINGTON · NIH-10691378
This study is looking at how the shape of our airways might affect the risk of developing lung diseases like COPD from air pollution, and it's for anyone interested in understanding how environmental factors can impact lung health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10691378 on ClinicalTrials.gov |
What this research studies
This research investigates how the structure of airways influences the development of lung diseases related to environmental pollution. The project aims to understand the relationship between airway morphology and the impact of air pollution on chronic obstructive pulmonary disease (COPD) through a combination of epidemiological studies and advanced imaging techniques. By analyzing data from diverse populations, the research seeks to identify specific airway characteristics that may increase vulnerability to the harmful effects of pollutants. This work is supported by a team of experts in various fields, ensuring a comprehensive approach to the problem.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic lung diseases, particularly those exposed to high levels of air pollution.
Not a fit: Patients with lung diseases not related to environmental factors or those living in areas with low pollution may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for lung diseases caused by environmental factors.
How similar studies have performed: Previous research has shown promising results in understanding the effects of air pollution on lung health, indicating that this approach has potential for significant findings.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SACK, CORALYNN SHAYNA — UNIVERSITY OF WASHINGTON
- Study coordinator: SACK, CORALYNN SHAYNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.